Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: A post-hoc analysis
Authors:
- Matti AaproMAMatti Aapro
- Sergei TjulandinSTSergei Tjulandin
- Paul BharPBPaul Bhar
- William GradisharWGWilliam Gradishar
Open Access
- 1 October 2011
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 20 (5) , 468-474
Abstract
No abstract availableKeywords
Funding Information
- Abraxis BioScience
This publication has 21 references indexed in Scilit:
- How Age Affects the Biology of Breast CancerClinical Oncology, 2009
- Treatment of breast cancer in older womenActa Oncologica, 2008
- Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric OncologyThe Lancet Oncology, 2007
- Breast Cancer in the ElderlyJournal of Clinical Oncology, 2007
- Taxanes in breast cancer: An updateCurrent Oncology Reports, 2007
- Taxanes in elderly breast cancer patientsCancer Treatment Reviews, 2004
- The natural history of breast carcinoma in the elderlyCancer, 2004
- Pharmacological Factors Influencing Anticancer Drug Selection in the ElderlyDrugs & Aging, 2003
- Magnetic Resonance Imaging of Nude Mice With Heterotransplanted High-Grade Squamous Cell CarcinomasInvestigative Radiology, 2002
- Cremophor ELEuropean Journal of Cancer, 2001